These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

222 related items for PubMed ID: 22144565

  • 1. Nicotine reduces antipsychotic-induced orofacial dyskinesia in rats.
    Bordia T, McIntosh JM, Quik M.
    J Pharmacol Exp Ther; 2012 Mar; 340(3):612-9. PubMed ID: 22144565
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Pharmacological and neurochemical differences between acute and tardive vacuous chewing movements induced by haloperidol.
    Egan MF, Hurd Y, Ferguson J, Bachus SE, Hamid EH, Hyde TM.
    Psychopharmacology (Berl); 1996 Oct; 127(4):337-45. PubMed ID: 8923569
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Possible antioxidant and neuroprotective mechanisms of FK506 in attenuating haloperidol-induced orofacial dyskinesia.
    Singh A, Naidu PS, Kulkarni SK.
    Eur J Pharmacol; 2003 Sep 12; 477(2):87-94. PubMed ID: 14519411
    [Abstract] [Full Text] [Related]

  • 16. Co-administration of nitric oxide (NO) donors prevents haloperidol-induced orofacial dyskinesia, oxidative damage and change in striatal dopamine levels.
    Bishnoi M, Chopra K, Kulkarni SK.
    Pharmacol Biochem Behav; 2009 Jan 12; 91(3):423-9. PubMed ID: 18789960
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Persistent catalepsy associated with severe dyskinesias in rats treated with chronic injections of haloperidol decanoate.
    Hyde TM, Egan MF, Wing LL, Wyatt RJ, Weinberger DR, Kleinman JE.
    Psychopharmacology (Berl); 1995 Mar 12; 118(2):142-9. PubMed ID: 7617800
    [Abstract] [Full Text] [Related]

  • 19. Ginkgo biloba leaf extract and alpha-tocopherol attenuate haloperidol-induced orofacial dyskinesia in rats: Possible implication of antiapoptotic mechanisms by preventing Bcl-2 decrease and Bax elevation.
    An HM, Tan YL, Shi J, Wang Z, Lv MH, Soares JC, Zhou D, Yang F, Zhang XY.
    Phytomedicine; 2016 Dec 01; 23(13):1653-1660. PubMed ID: 27823630
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.